Abbvie Inc. vs Zimmer Biomet Holdings, Inc.
ABBV vs ZBH — side-by-side comparison from reported financials. ABBV leads 7, ZBH leads 5 of 12 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Zimmer Biomet Holdings, Inc.
ZBH · Healthcare
$89.00+0.14%Mixed
| Metric | ABBV | ZBH |
|---|---|---|
| Price | $276.43 | $89.00 |
| Market cap | $488B | $17.0B |
| Revenue (TTM) | $64.4B | $8.51B |
| Revenue growth | +1.8% | +5.8% |
| Net margin | 9.8% | 9.5% |
| Free cash flow | $18.2B | $1.52B |
| Net cash (debt) | ($56.2B) | ($6.34B) |
| 1-year price return | +19.8% | -8.6% |
| P/E | 77.4 | 21.5 |
| P/E vs own history (cheap-side %) | 23% | 96% |
| Dividend yield | 2.45% | 1.09% |
| Return on equity | 96% | 6% |
| Altman Z-score | 2.33 | 2.15 |
| CV checks passed | 9 of 11 | 11 of 11 |
| Employees | 57,000 | 17,000 |
Full résumé-style profiles: ABBV CV · ZBH CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.